Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infection

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3614-3619

  Burghaus, Petra A ^a,e   Wellde, Bruce T ^b   Hall, Ted ^b   Richards, Roberta L ^b   Egan, Andrea F ^c   Riley, Eleanor M ^c   Ripley Ballou, W ^b   Holder, Anthony A ^a,d  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d Division of Parasitology   (United Kingdom)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MEMBRANE PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; AOTUS; ARTICLE; ESCHERICHIA COLI; EXPRESSION VECTOR; IMMUNOGENICITY; INFECTION PREVENTION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; VACCINE PRODUCTION;

EID: 0029739330     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3614-3619.1996     Document Type: Article

References (35)

1. Alving, C. R., S. Shichijo, I. Mattsby-Baltzer, R. L. Richards, and N. M. Wassef. 1993. Preparation and use of liposomes in immunological studies, p. 317-343. In G. Gregoriadis (ed.), Liposome technology, 2nd ed., vol. 3. CRC Press, Boca Raton, Fla.
2. Berzins, K., H. Perlmann, B. Wåhlin, H.-P. Ekre, B. Högh, E. Petersen, B. Wellde, M. Schoenbechler, J. Williams, J. Chulay, and P. Perlmann. 1991. Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA. Infect. Immun. 59:1500-1506.
3. Blackman, M. J., H.-G. Heidrich, S. Donachie, J. S. McBride, and A. A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
4. Blackman, M. J., I. T. Ling, S. C. Nicholls, and A. A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-34.
5. Blackman, M. J., T. J. Scott-Finnigan, S. Shai, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-390.
6. Burghaus, P. A., and A. A. Holder. 1994. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol. Biochem. Parasitol. 64:165-169.
7. Chang, S. P., H. L. Gibson, C. T. Lee-Ng, P. J. Barr, and G. S. N. Hui. 1992 A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555.
8. Chappel, J. A., and A. A. Holder. 1993. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60:303-312.
9. Cohen, J. 1994. Frontiers in medicine: vaccines - bumps on the vaccine road. Science 265:1371-1372.
10. Cooper, J. A. 1993. Merozoite surface antigen-1 of Plasmodium. Parasitol. Today 9:50-54.
11. Cooper, J. A., L. T. Cooper, and A. J. Saul. 1992. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA-1. Mol. Biochem. Parasitol. 51:301-312.
12. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface pro- tein 1 induces a protective immune response in mice. Infect. Immun. 61:2462-2467.
13. Daly, T. M., and C. A. Long. 1995. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 155:236-243.
14. Diggs, C. L., W. R. Ballou, and L. H. Miller. 1993. The major merozoite surface protein as a malaria vaccine target. Parasitol. Today 9:300-302.
15. Egan, A. F., J. A. Chappel, P. A. Burghaus, J. S. Morris, J. S. McBride, A. A. Holder, D. C. Kaslow, and E. M. Riley. 1995. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1-19, the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 63:456-466.
16. Egan, A. F., J. Morris, G. Barnish, S. Allen, B. M. Greenwood, D. C. Kaslow, A. A. Holder, and E. M. Riley. 1996.Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173:765-769.
17. Fries, L. F., D. M. Gordon, R. L. Richards, J. E. Egan, M. R. Hollingdale, M. Gross, C. Silverman, and C. R. Alving. 1992. Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc. Natl. Acad. Sci. USA 89:358-362.
18. Høgh, B., N. T. Marbiah, P. A. Burghaus, and P. K. Andersen. 1995. Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, West Africa, in which malaria is highly endemic. Infect. Immun. 65:4034-4038.
19. Holder, A. A. 1993. Developments with anti-malaria vaccines. Ann. N. Y. Acad. Sci. 700:7-21.
20. Howard, R. J., and B. L. Pasloske. 1993. Target antigens for asexual malaria vaccine development. Parasitol. Today 9:369-374.
21. Hui, G. S. N., and S. P. Chang. 1992. Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants. Exp. Parasitol. 75:155-157.
22. 19 expressed in S. cerevisiae. J. Immunol. 153:2544-2553.
23. Kaslow, D. C., G. Hui, and S. Kumar. 1994. Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP1-19) variants secreted from Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 63:283-289.
24. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:1-8.
25. a.Ling, I. T., et al. Unpublished data.
26. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunisation against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
27. Miller, L. H., T. Roberts, M. Shahabuddin, and T. F. McCutchan. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP1). Mol. Biochem. Parasitol. 59:1-14.
28. Müller, H.-M., K. Früh, A. von Brunn, F. Esposito, S. Lombardi, A. Crisanti, and H. Bujard. 1989. Development of the human immune response against the major merozoite surface protein (gp190) of Plasmodium falciparum. Infect. Immun. 57:3765-3769.
29. O'Dea, K. P., P. G. McKean, W. Jarra, and K. N. Brown. 1996. A single copy merozoite antigen and immune evasion. Parasite Immunol. 18:165-172.
30. Pirson, P. J., and M. E. Perkins. 1985. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J. Immunol. 134:1946-1951.
31. Riley, E. M., S. J. Allen, J. G. Wheeler, M. J. Blackman, S. Bennett, B. Takacs, H. J. Schoenfeld, A. A. Holder, and B. M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. 14:321-337.
32. Riley, E. M., S. Morris-Jones, M. J. Blackman, B. M. Greenwood, and A. A. Holder. 1993. A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal transmission. Parasite Immunol. 15:513-524.
33. Tolle, R., K. Früh, O. Doumbo, O. Koita, M. N'Diaye, A. Fischer, K. Dietz, and H. Bujard. 1993. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections. Infect. Immun. 61:40-47.
34. Udhayakumar, V., D. Anyona, S. Kariuki, Y. P. Shi, P. B. Bloland, O. H. Branch, W. Welss, B. L. Nahlen, D. C. Kaslow, and A. A. Lal. 1995. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J. Immunol. 154:6022-6030.
35. Wellde, B. T., and T. Hall. Unpublished data.